[Myeloproliferative neoplasms and endothelial progenitor cells]
Xue Han1, Fang Wang1, Ye Chen1
1Department of Hematology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Abstract:
JAK2V617F is a novel oncogene involved in myeloproliferative neoplasms (MPN) and closely related to its vascular complications. Recent researches found the vascular endothelial injury in patients with MPN. It is increasingly being recognized that endothelial cells and endothelial progenitor cells (EPC) play an important role in MPN. Here, the pathogenesis of the EPC JAK2V617F mutation and peripheral blood EPC counts in patients with MPN or with vascular complications are reviewed.
More Related Videos
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Production of Formed Elements
Most HSCs commit to...
Lineage Commitment
Multipotency of Hematopoietic Stem Cells
Hematopoiesis
Regulation of Hematopoietic Stem Cells


